ReviewWorld journal of microbiology & biotechnology2026
α-glucosylglycerol: biological activities, emerging applications, and advances in sustainable biomanufacturing.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glucosylglycerol (αGG, 2-O-α-D-glucopyranosyl-sn-glycerol) is a compatible solute produced by plants and diverse microorganisms under osmotic stress, consisting of glucose and glycerol linked via an α-1,2-glycosidic bond. Its high stability, low sweetness, and biocompatibility support growing interest in αGG as a functional ingredient for cosmetic and food applications and as a candidate for potential health-related uses, with preliminary reports of effects including skin hydration and barrier support, non-cariogenicity, and possible modulation of carbohydrate digestion. Despite these advantages, industrial deployment is still hindered by low productivity, by-product formation, and costly purification across existing routes, including extraction, chemical synthesis, microbial fermentation, and enzymatic production. This review integrates recent advances from microbiology and biotechnology, covering αGG-producing microbes and pathway insights, cell-factory engineering to improve precursor supply and redirect carbon flux, and regulation of transport and stress responses to enhance extracellular accumulation. Selective biocatalytic strategies for the synthesis of αGG based on various enzymes are also summarized, and the contributions of enzyme engineering, immobilization, whole-cell catalysis, and multi-enzyme cascade design to improved stability, selectivity, and space-time yield are highlighted. Finally, scale-up and process integration considerations are addressed, and actionable directions are proposed to enable sustainable and economically viable αGG manufacturing for food and health applications.
Indexed as
Identifiers
41724844What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.